RESEARCH

METHEDOLOGY AND
INTELLECTUAL
PROPETY RIGHTS STUDENT
ASSIGNMENT-
NAME: -VAFA
DIFFERENT
CITATION TYPES USN:-
4AL21CV014
Nicotinamide
mononucleotide
SEM :- 5th SEM-
(NMN) as an anti-
aging health product
A-Sec
promises and safety
concerns
1. United Nations (UN), Department of Economic
and Social Affairs, Population Division. World
population ageing 2019: highlights
(ST/ESA/SER.A/430).
New York, USA: United Nations; 2019.
CHIGAGO Nadeeshani, Harshani, Jinyao Li,
Tianlei Ying, Baohong Zhang, and
Jun Lu. "Nicotinamide
mononucleotide (NMN) as an anti-
aging health product–promises and
safety concerns." Journal of
advanced research 37 (2022): 267-
278.
HARWARD Nadeeshani, H., Li, J., Ying, T.,
Zhang, B. and Lu, J., 2022.
Nicotinamide mononucleotide
(NMN) as an anti-aging health
product–promises and safety
concerns. Journal of advanced
research, 37, pp.267-278.
MLA Nadeeshani, H., Li, J., Ying, T.,
Zhang, B. and Lu, J., 2022.
Nicotinamide mononucleotide
(NMN) as an anti-aging health
product–promises and safety
concerns. Journal of advanced
research, 37, pp.267-278.
APA Nadeeshani, H., Li, J., Ying, T.,
Zhang, B., & Lu, J. (2022).
Nicotinamide mononucleotide
(NMN) as an anti-aging health
product–promises and safety
concerns. Journal of advanced
research, 37, 267-278

2. Anti-aging medicine: the legal issues: legal issues

associated with the current and future practice of
anti-aging medicine
MLA Wasser, Solomon P. "Current
findings, future trends, and unsolved
problems in studies of medicinal
mushrooms." Applied microbiology
and biotechnology 89 (2011): 1323-
1332.

APA Wasser, S. P. (2011). Current

findings, future trends, and unsolved
problems in studies of medicinal
 mushrooms. Applied microbiology
and biotechnology, 89, 1323-1332.

CHICAGO Wasser, Solomon P. "Current

findings, future trends, and unsolved
problems in studies of medicinal
mushrooms." Applied microbiology
and biotechnology 89 (2011): 1323-
1332.

HARVARD Wasser, S.P., 2011. Current findings,

future trends, and unsolved problems
in studies of medicinal
mushrooms. Applied microbiology
and biotechnology, 89, pp.1323-1332.

3. Nicotinamide mononucleotide, an intermediate of

NAD+ synthesis, protects the heart from ischemia
and reperfusion
MLA Yamamoto, Takanobu, et al.
"Nicotinamide mononucleotide, an
intermediate of NAD+ synthesis,
protects the heart from ischemia and
reperfusion." PloS one 9.6 (2014):
e98972.
APA Yamamoto, Takanobu, et al.
"Nicotinamide mononucleotide, an
intermediate of NAD+ synthesis,
protects the heart from ischemia and
reperfusion." PloS one 9.6 (2014):
e98972.

CHICAGO Yamamoto, Takanobu, Jaemin Byun,

Peiyong Zhai, Yoshiyuki Ikeda,
Shinichi Oka, and Junichi Sadoshima.
"Nicotinamide mononucleotide, an
intermediate of NAD+ synthesis,
protects the heart from ischemia and
reperfusion." PloS one 9, no. 6
(2014): e98972.

HAEVARD Yamamoto, T., Byun, J., Zhai, P.,

Ikeda, Y., Oka, S. and Sadoshima, J.,
2014. Nicotinamide mononucleotide,
an intermediate of NAD+ synthesis,
protects the heart from ischemia and
reperfusion. PloS one, 9(6), p.e98972.

4. Discoveries of nicotinamide riboside as a nutrient

and conserved NRK genes establish a Preiss-
Handler independent route to NAD+ in fungi and
humans
MLA Bieganowski, Pawel, and Charles
Brenner. "Discoveries of nicotinamide
riboside as a nutrient and conserved
NRK genes establish a Preiss-Handler
independent route to NAD+ in fungi
and humans." Cell 117.4 (2004): 495-
502.

APA Bieganowski, P., & Brenner, C.

(2004). Discoveries of nicotinamide
riboside as a nutrient and conserved
NRK genes establish a Preiss-Handler
independent route to NAD+ in fungi
and humans. Cell, 117(4), 495-502.

CHICAGO Bieganowski, Pawel, and Charles

Brenner. "Discoveries of nicotinamide
riboside as a nutrient and conserved
NRK genes establish a Preiss-Handler
independent route to NAD+ in fungi
and humans." Cell 117, no. 4 (2004):
495-502.

HARVARD Bieganowski, P. and Brenner, C.,

2004. Discoveries of nicotinamide
riboside as a nutrient and conserved
NRK genes establish a Preiss-Handler
independent route to NAD+ in fungi
and humans. Cell, 117(4), pp.495-502.
5. Size exclusion chromatography method for
purification of nicotinamide mononucleotide (NMN)
from bacterial cells
MLA Marinescu, George Cătălin, Roua-
Gabriela Popescu, and Anca
Dinischiotu. "Size exclusion
chromatography method for
purification of nicotinamide
mononucleotide (NMN) from
bacterial cells." Scientific reports 8.1
(2018): 4433.

APA Marinescu, G. C., Popescu, R. G., &

Dinischiotu, A. (2018). Size
exclusion chromatography method
for purification of nicotinamide
mononucleotide (NMN) from
bacterial cells. Scientific
reports, 8(1), 4433.

CHICAGO Marinescu, George Cătălin, Roua-

Gabriela Popescu, and Anca
Dinischiotu. "Size exclusion
chromatography method for
purification of nicotinamide
mononucleotide (NMN) from
bacterial cells." Scientific reports 8,
no. 1 (2018): 4433.
HARVARD Marinescu, G.C., Popescu, R.G. and
Dinischiotu, A., 2018. Size exclusion
chromatography method for
purification of nicotinamide
mononucleotide (NMN) from
bacterial cells. Scientific
reports, 8(1), p.4433.

6. Nicotinamide mononucleotide: exploration of

diverse therapeutic applications of a potential
molecule
MLA Poddar, Saikat Kumar, et al.
"Nicotinamide mononucleotide:
exploration of diverse therapeutic
applications of a potential
molecule." Biomolecules 9.1 (2019):
34.

APA Poddar, S. K., Sifat, A. E., Haque, S.,

Nahid, N. A., Chowdhury, S., &
Mehedi, I. (2019). Nicotinamide
mononucleotide: exploration of diverse
therapeutic applications of a potential
molecule. Biomolecules, 9(1), 34.
CHICAGO Poddar, Saikat Kumar, Ali Ehsan Sifat,
Sanjana Haque, Noor Ahmed Nahid,
Sabiha Chowdhury, and Imtias
Mehedi. "Nicotinamide
mononucleotide: exploration of diverse
therapeutic applications of a potential
molecule." Biomolecules 9, no. 1
(2019): 34.

HARVARD Poddar, S.K., Sifat, A.E., Haque, S.,

Nahid, N.A., Chowdhury, S. and
Mehedi, I., 2019. Nicotinamide
mononucleotide: exploration of diverse
therapeutic applications of a potential
molecule. Biomolecules, 9(1), p.34.

7. Long-term administration of nicotinamide

mononucleotide mitigates age-associated
physiological decline in mice
MLA Mills, Kathryn F., et al. "Long-term
administration of nicotinamide
mononucleotide mitigates age-
associated physiological decline in
mice." Cell metabolism 24.6 (2016):
795-806.

APA Mills, K. F., Yoshida, S., Stein, L. R.,

Grozio, A., Kubota, S., Sasaki, Y., ...
 & Imai, S. I. (2016). Long-term
administration of nicotinamide
mononucleotide mitigates age-
associated physiological decline in
mice. Cell metabolism, 24(6), 795-
806.

CHICACO Mills, Kathryn F., Shohei Yoshida,

Liana R. Stein, Alessia Grozio,
Shunsuke Kubota, Yo Sasaki, Philip
Redpath et al. "Long-term
administration of nicotinamide
mononucleotide mitigates age-
associated physiological decline in
mice." Cell metabolism 24, no. 6
(2016): 795-806.

HARVARD Mills, K.F., Yoshida, S., Stein, L.R.,

Grozio, A., Kubota, S., Sasaki, Y.,
Redpath, P., Migaud, M.E., Apte,
R.S., Uchida, K. and Yoshino, J.,
2016. Long-term administration of
nicotinamide mononucleotide
mitigates age-associated
physiological decline in mice. Cell
metabolism, 24(6), pp.795-806.
8. NAD+ supplementation normalizes key
Alzheimer’s features and DNA damage responses in
a new AD mouse model with introduced DNA repair
deficiency
MLA Hou, Yujun, et al. "NAD+
supplementation normalizes key
Alzheimer’s features and DNA
damage responses in a new AD mouse
model with introduced DNA repair
deficiency." Proceedings of the
National Academy of Sciences 115.8
(2018): E1876-E1885.

APA Hou, Y., Lautrup, S., Cordonnier, S.,

Wang, Y., Croteau, D. L., Zavala, E.,
... & Bohr, V. A. (2018). NAD+
supplementation normalizes key
Alzheimer’s features and DNA
damage responses in a new AD mouse
model with introduced DNA repair
deficiency. Proceedings of the
National Academy of Sciences, 115(8),
E1876-E1885.

CHICACO Hou, Yujun, Sofie Lautrup, Stephanie

Cordonnier, Yue Wang, Deborah L.
Croteau, Eduardo Zavala, Yongqing
Zhang et al. "NAD+ supplementation
normalizes key Alzheimer’s features
 and DNA damage responses in a new
AD mouse model with introduced
DNA repair deficiency." Proceedings
of the National Academy of
Sciences 115, no. 8 (2018): E1876-
E1885.

HARVARD Hou, Y., Lautrup, S., Cordonnier, S.,

Wang, Y., Croteau, D.L., Zavala, E.,
Zhang, Y., Moritoh, K., O’Connell,
J.F., Baptiste, B.A. and Stevnsner,
T.V., 2018. NAD+ supplementation
normalizes key Alzheimer’s features
and DNA damage responses in a new
AD mouse model with introduced
DNA repair deficiency. Proceedings
of the National Academy of
Sciences, 115(8), pp.E1876-E1885.

9. Implications of altered NAD metabolism in

metabolic disorders
MLA Okabe, Keisuke, et al. "Implications
of altered NAD metabolism in
metabolic disorders." Journal of
biomedical science 26.1 (2019): 1-13.

APA Okabe, K., Yaku, K., Tobe, K., &

Nakagawa, T. (2019). Implications of
 altered NAD metabolism in metabolic
disorders. Journal of biomedical
science, 26(1), 1-13.

CHICACO Okabe, Keisuke, Keisuke Yaku,

Kazuyuki Tobe, and Takashi
Nakagawa. "Implications of altered
NAD metabolism in metabolic
disorders." Journal of biomedical
science 26, no. 1 (2019): 1-13.

HARVARD Okabe, K., Yaku, K., Tobe, K. and

Nakagawa, T., 2019. Implications of
altered NAD metabolism in metabolic
disorders. Journal of biomedical
science, 26(1), pp.1-13.

10. β-nicotinamide mononucleotide (NMN)

production in Escherichia coli
MLA Marinescu, George Cătălin, et al. "β-
nicotinamide mononucleotide (NMN)
production in Escherichia
coli." Scientific reports 8.1 (2018):
12278.

APA Marinescu, G. C., Popescu, R. G.,

Stoian, G., & Dinischiotu, A. (2018).
β-nicotinamide mononucleotide
 (NMN) production in Escherichia
coli. Scientific reports, 8(1), 12278.

CHICACO Marinescu, George Cătălin, Roua-

Gabriela Popescu, Gheorghe Stoian,
and Anca Dinischiotu. "β-
nicotinamide mononucleotide (NMN)
production in Escherichia
coli." Scientific reports 8, no. 1
(2018): 12278.

HARVARD Marinescu, G.C., Popescu, R.G.,

Stoian, G. and Dinischiotu, A., 2018.
β-nicotinamide mononucleotide
(NMN) production in Escherichia
coli. Scientific reports, 8(1), p.12278.

DIFFERECES:-
1.IEEE citation format consists of:
Numerical in-text citations appearing in brackets
A numbered reference list with full source information
2.ACSE (American Council of Science Editors):
Often used in the sciences.
Uses a citation-sequence system where sources are
numbered in the order they appear in the text.
Provides rules for formatting references in different
types of scientific documents.
3.Harvard:
A parenthetical author-date citation style used in
various disciplines.
Citations include the author's name and the publication
year, e.g., (Author, Year).
The full reference list is arranged alphabetically by the
author's last name.
4.Chicago:
Has both notes and bibliography (humanities) and
author-date (sciences and social sciences) systems.
In the notes and bibliography system, citations are
usually in the form of footnotes or endnotes with a
bibliography at the end.
In the author-date system, citations include the author's
name and the publication year in the text, with a
corresponding reference list.
5.Vancouver:
Commonly used in biomedical and health sciences.
Uses a numeric citation style similar to IEEE and
ACSE.
Sources are numbered in the order they appear in the
text, and the references are listed in numerical order at
the end.